Biosynthesis of a new skyllamycin analogue in Streptomyces nodosus: a cytochrome P450 forms an epoxide in the cinnamoyl chain

Yuhao Song,Jose A Amaya,Vidhi C Murarka,Hugo Mendez,Mark Hogan,Jimmy Muldoon,Paul Evans,Yannick Ortin,Steven L Kelly,David C Lamb,Thomas L Poulos,Patrick Caffrey,Jose Amaya,jimmy muldoon,Steven Kelly,David Lamb,Thomas Poulos
DOI: https://doi.org/10.1039/d4ob00178h
2024-03-19
Organic & Biomolecular Chemistry
Abstract:Activation of a silent gene cluster in Streptomyces nodosus leads to synthesis of a cinnamoyl-containing non-ribosomal peptide (CCNP) that is related to skyllamycins. This novel CCNP was isolated and its structure was interrogated using mass spectrometry and nuclear magnetic resonance spectroscopy. The isolated compound is an oxidised skyllamycin A in which an additional oxygen atom is incorporated in the cinnamoyl side-chain in the form of an epoxide. The gene for the epoxide-forming cytochrome P450 was identified by targeted disruption. The enzyme was overproduced in Escherichia coli and a 1.43 Å high-resolution crystal structure was determined. This is the first crystal structure for a P450 that forms an epoxide in a substituted cinnamoyl chain of a lipopeptide. These results confirm the proposed functions of P450s encoded by biosynthetic gene clusters for other epoxidized CCNPs and will assist investigation of how epoxide stereochemistry is determined in these natural products.
chemistry, organic
What problem does this paper attempt to address?
The paper attempts to address the synthesis of a novel tianamycin analog (oxy-skyllamycin) in the actinomycete *Streptomyces nodosus* through gene cluster activation and to study its biosynthetic mechanism. Specifically, the paper explores the following points: 1. **Discovery of the new compound**: By activating the silent gene cluster in *Streptomyces nodosus*, researchers discovered a new tianamycin analog with a molecular mass 16 mass units higher than tianamycin A. 2. **Structural identification**: Through mass spectrometry (MS) and nuclear magnetic resonance (NMR) analysis, the structure of this new compound was determined, revealing the presence of an epoxide group in the cinnamoyl side chain. 3. **Gene function validation**: Through gene knockout experiments, the cytochrome P450 enzyme (P450Sky2) responsible for forming the epoxide group was identified. The results showed that when the P450Sky2 gene was knocked out, only tianamycin A could be detected, not oxy-skyllamycin. 4. **Enzyme structural analysis**: By heterologous expression and crystallographic analysis, the high-resolution crystal structure of P450Sky2 was obtained. This helps to further understand the role of P450Sky2 in the biosynthesis of tianamycin analogs. In summary, the paper aims to reveal the new structure of tianamycin analogs and their biosynthetic mechanism through gene cluster activation, chemical structure characterization, and enzyme function validation, laying the foundation for the further development of novel anticancer drugs and antibiotics.